Trial Details

COMPLETED
Basic Information
Clinical ID c1189
Identifier NCT04004611
Trial Title A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC)
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Ulcerative Colitis
Interventions DRUG: Mirikizumab
Participant Information
Sponsor Eli Lilly and Company
City Orange
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2020-05-18
Primary Completion Date 2023-03-15
Completion Date 2023-03-15